It’s important to report possible adverse events after medicine authorization. Consequently the benefit-risk ratio of the medicinal products can continuously be evaluated. Healthcare professionals are required to report all possible adverse events via the Federal Agency for Medicines and Health Products or via our contact page.
Belgium:
Federal Agency for Medicines and Health Products
Division Vigilance
Avenue Galilée 5/03
1210 BRUSSEL
Site internet: www.notifieruneffetindesirable.be
e-mail: adr@afmps.be
Luxembourg :
Direction de la Santé
Division de la Pharmacie et des Médicaments
20, rue de Bitbourg
L-1273 Luxembourg-Hamm
Tél.: (+352) 2478 5592
e-mail: pharmacovigilance@ms.etat.lu
Link pour le formulaire : https://guichet.public.lu/fr/entreprises/sectoriel/sante/medecins/notification-effets-indesirables-medicaments.html
